Medical device company Zavation recently announced it received FDA 510(k) clearance to market the Ti3Z Interbody System.
This device is used as a lumbar intervertebral body fusion device and is intended for patients who have had 6 months of nonoperative treatment. The device’s interbody implants have five main configurations (anterior lumbar interbody fusion, LLIF, transforaminal lumbar interbody fusion, transforaminal posterior lumbar interbody fusion and posterior lumbar interbody fusion), which allow for multiple surgical technique options.
“Our research and development team combined the best of both worlds. The interior lattice structure promotes osseointegration and optimal elasticity, while the external edges of the implant maintains mechanical stability,” Jeffrey Johnson, CEO of Zavation, said.
Zavation plans on immediately launching the Ti3Z Interbody System in the U.S. market.